Reuters
•US NIH begins human trials of 'universal' flu vaccine
92% Informative
FluMos-v2 is designed to offer protection against four strains of the influenza A virus and two strains of influenza B virus.
The study is expected to enroll 24 healthy volunteers, aged between 18 and 50 , who will receive two intramuscular injections.
Moderna vaccine maker Moderna said on Wednesday its flu vaccine had generated a stronger immune response against all four A and B strains.
VR Score
97
Informative language
98
Neutral language
87
Article tone
formal
Language
English
Language complexity
57
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
3
Source diversity
3
Affiliate links
no affiliate links